SK Chemicals Co.,Ltd (KRX: 285130)

Market Cap	849.32B
Revenue (ttm)	1.65T
Net Income (ttm)	-15.61B
Shares Out	19.19M
EPS (ttm)	-329.37
PE Ratio	n/a
Forward PE	107.92
Dividend	650.00 (1.38%)
Ex-Dividend Date	Aug 8, 2024

Volume	2,150
Open	45,700
Previous Close	46,200
Day's Range	45,450 - 46,000
52-Week Range	39,100 - 74,100
Beta	0.95
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 6, 2025

About SK Chemicals Co.,Ltd

SK Chemicals Co.,Ltd provides chemicals and life sciences products and solutions in South Korea and internationally. The company develops copolysters, coating and adhesive materials, engineering plastics, prepergs, bio materials, and 3D printing materials, as well as specialty chemicals, pharmaceutical products, and vaccines. It has a collaborate agreement with Standigm, Inc. to develop an AI-driven drug candidate for non-alcoholic steatohepatitis. The company was founded in 1969 and is headquartered in Seongnam-si, South Korea.

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1969
• Employees: 1,633
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 285130

Financial Performance

In 2023, SK Chemicals Co.,Ltd's revenue was 1.75 trillion, a decrease of -4.40% compared to the previous year's 1.83 trillion. Earnings were 35.69 billion, a decrease of -81.34%.